RNAC
Cartesian Therapeutics, Inc. · Healthcare
Director and 10% owner Timothy A Springer bought $7.4M of Cartesian Therapeutics, Inc.
Bought$7,373,527
$17.07Price
431,940Shares
+5%Stake
What RNAC did for a copier
- $1,000 copied at Mon, Nov 18 close, $18.57
- $912
- S&P 500, same days
- −0.3%
Measured over 30 trading days, to the Jan 2 close.
Timothy A Springer's record
10 other buys with 3 months of prices since 2017: on average −4.1% against the S&P 500, and 6 of 10 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Nov 14. Filed Mon, Nov 18, 2:35 PM ET, during the session. Returns use the Nov 18 close and the Jan 2 close. Not investment advice.